Trial Profile
A study assessing the predictive markers of efficacy for the combination therapy of basal insulin and liraglutide when switched from basal bolus insulin therapy in type 2 diabetes patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 24 Jul 2017
Price :
$35
*
At a glance
- Drugs Liraglutide (Primary) ; Insulin
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 24 Jul 2017 New trial record
- 13 Jun 2017 Results presented at the 77th Annual Scientific Sessions of the American Diabetes Association